More reads

• In a test for AI, a buzzy machine learning startup inks drug discovery deal with Gilead. (STAT)
• Big spending from AbbVie, Pfizer pushes pharma's 2018 ad spend to $6.5 billion. (FiercePharma)
• First U.S. patients treated with CRISPR as gene-editing human trials get underway. (NPR)